Value Partners’s iShares Biotechnology ETF IBB Stock Holding History

Value Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$1.18M	Buy	13,800 +8,700	+171%	+$781K	0.75%	12
2016 Q1	$443K	Buy	+5,100	New	+$456K	0.4%	17
2015 Q1	–	Sell	-17,745	Closed	-$1.79M	–	15
2014 Q4	$1.79M	Hold	17,745	–	–	2.93%	16
2014 Q3	$1.62M	Hold	17,745	–	–	2.85%	17
2014 Q2	$1.52M	Sell	17,745 -22,455	-56%	-$1.77M	2.14%	19
2014 Q1	$3.17M	Buy	+40,200	New	+$3.35M	3.65%	10

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Value Partners's IBB Position: Q2 2016 in Review

Value Partners increased its iShares Biotechnology ETF (IBB) stake by 171% in Q2 2016, buying an estimated $781K and bringing the position to 13,800 shares worth $1.18M. The position accounts for 0.75% of the portfolio, ranked #12.

Value Partners first reported a position in IBB in Q1 2014 and has held it in 6 quarters since. The position peaked at $3.17M in Q1 2014. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Value Partners held 13,800 shares of iShares Biotechnology ETF worth $1.18M as of Q2 2016.
Value Partners bought 8,700 iShares Biotechnology ETF shares in Q2 2016, an estimated $781K.
iShares Biotechnology ETF made up 0.75% of Value Partners's portfolio in Q2 2016, its #12 holding.
Value Partners first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 6 quarters since.
Value Partners's iShares Biotechnology ETF position peaked at $3.17M in Q1 2014.
428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Value Partners's 13F filing for Q2 2016, filed 12 Aug 2016.